Smoothened (Smo) is the essential transducer of Sonic hedgehog (Shh) signaling, which regulates cell fate and proliferation during embryogenesis. We identified a novel mouse mutant, cabbie (cbb), and found that its cause is a missense mutation in Smo. We showed the Smo cbb mutation is insensitive to the Shh agonist SAG, perhaps due to the disruption of SAG binding. We characterized Smo cbb for defects in craniofacial and skeletal development, as well as neural tube patterning, and revealed Smo cbb affected processes that require the highest levels of Shh activity. Smo is normally enriched in cilia upon Shh stimulation; however, we detected inefficient enrichment of Smo in Smo cbb mutants whether we stimulated with Shh or SAG. Taken together, our data suggest that the highest levels of vertebrate Hedgehog signaling activity require efficient Smo ciliary enrichment.
Introduction
Hedgehog (Hh) signaling is essential for embryogenesis and tissue homeostasis [1, 2] . In vertebrates, there are three classes of Hh ligands: Sonic (Shh), Indian (Ihh), and Desert hedgehog (Dhh), all of which require the G protein-coupled receptor (GPCR) Smoothened (Smo) for signal transduction [3] [4] [5] [6] . In the absence of Hh ligand, the Hh receptor Patched1 (Ptch1) inhibits Smo, which results in the downstream Gli transcription factors being cleaved to transcriptional repressors. Upon binding of Hh ligand to Ptch1, the inhibition is lost, leading to Smo activation and downstream signaling. The activation of Smo involves multiple steps that include conformational change, phosphorylation [7] [8] [9] , and ciliary enrichment [7, [10] [11] [12] . The processes that regulate Smo activation are part of the mechanism by which the level of Hh response is regulated for specific biological processes. Too much Hh leads to tumorigenesis, whereas too little leads to birth defects, including skeletal and craniofacial anomalies [13] [14] [15] [16] [17] [18] [19] [20] .
In vertebrates, primary cilia, the solitary microtubule-based projections found on virtually all cell types, are required for Hh signal transduction [21] . Cilia are built and maintained via intraflagellar transport, which uses kinesin and dynein motors for anterograde and retrograde traffic, respectively. The core Hh pathway components traffic dynamically in and out of cilia in a Hh ligand-dependent manner. In the absence of Shh, Ptch1 is visible in cilia [22] . Upon stimulation with Shh, Ptch1 becomes undetectable in cilia, whereas Smo is enriched [23] . This enrichment, while not sufficient for Smo activation, is considered a necessary step in activating Smo [24] .
Smo is a 7-transmembrane domain GPCR characterized by a large cysteine-rich domain (CRD) at its amino terminus, which plays an essential role in Smo dimerization and function [25] . The Smo CRD is known to associate with sterols, and recent evidence shows cholesterol can directly activate Smo, consistent with the findings that impaired cholesterol synthesis in Smith-Lemli-Opitz syndrome impairs Smo activation [26] [27] [28] [29] . However, the exact processes involved in activation of Smo remain uncharacterized. Methods to measure Smo activation have been limited to downstream processes such as Smo phosphorylation [7] [8] [9] , trafficking [10, 11, 30] , and transcriptional pathway output. Smo activation may involve its phosphorylation at multiple sites in its C-terminal tail, which induce a conformational change of Smo to an active state [7] . It's unclear where this conformational change occurs, as there is evidence that Smo continuously cycles through the cilium [31] . Graded increases in Hh stimulation induce increasing amounts of phosphorylation carried out by several kinases, including PKA, CK1α GRK2, and CK1γ [7, 32] .
Smo has a heptahelical ligand-binding domain known to interact with several exogenous compounds that have helped us better understand Smo activation and how it relates to the primary cilium. For instance, Smoothened agonist (SAG) directly activates Smo, bypassing Ptch1-mediated inhibition, and enriches Smo in the cilium [24, 33, 34] . The exact mechanism of ciliary Smo enrichment involves several proteins, including β-arrestin and kinesin motors [30] . In cells lacking cilia, SAG treatment induces partial phosphorylation of Smo, which can be blocked by inhibiting CK1α [32] .
In mice, loss of Smo is lethal just prior to embryonic day 9.5 (E9.5) since there is no transduction of signaling from Shh, Ihh, or Dhh [6, 35] . The roles of Shh and Ihh in processes like craniofacial and skeletal development as well as neural patterning stem largely from work on Shh or Ihh mutant mice. Shh signaling exerts a strong influence on craniofacial development, and small changes to the pathway output can dramatically alter the facial midline [36] . Between E9.5 and E10.5, Shh expression slowly increases in the pharyngeal endoderm, along the midline of the facial ectoderm, and in the ventral forebrain neuroectoderm [37] . Here, Shh expression promotes neural crest cell survival and is essential for craniofacial organization, especially for structures in the midline. The olfactory placodes and nasal pits normally develop bilaterally in the ectoderm overlying the ventral forebrain. In embryos without Smo or Shh, a single nasal pit is located medially, indicating Hh signaling is required for proper craniofacial separation [6, 35, 38] . Loss of Shh disrupts the bilateral symmetry of facial development, resulting in defects such as cyclopia and holoprosencephaly; these defects are well documented in humans and mice [17, 38, 39] . Shh promotes the development of skeletal tissues of the limb buds and digits, spine, ribs, face, and skull [38] . At birth, the long bones of the forelimb (the humerus, radius, and ulna) are ossified, along with centers at the base of each digit. Ihh inhibits chondrocyte differentiation and instead supports bone ossification by promoting chondrocyte proliferation in cartilaginous tissues, and facilitates bone lengthening in the limbs at the growth plate [40] .
Shh plays a critical role in specifying the cell fates of neural progenitor cells in the developing neural tube [38] . Shh ligand is expressed in the notochord and produces a ventral-to-dorsal activity gradient that determines specific cell fates based on the level of Shh activity [41] . For example, the cells at the ventral midline of the neural tube experience the highest level of Shh activity and are specified as floor plate expressing FoxA2 and Shh [42] . The cells adjacent to the floor plate express Nkx2.2, while the next adjacent domain expresses Olig2 [43, 44] . The level of Shh activity integrates the concentration and duration a progenitor cell is exposed to ligand [45] [46] [47] . Smo null mutants specify no ventral cell fates [6, 35] .
In this study, we reveal that an N-ethyl-N-nitrosourea (ENU)-induced mouse mutant, cabbie (cbb), is a novel allele of Smo. We identified cbb in the course of a forward genetic mouse screen for recessive mutations affecting embryonic neural development and picked up cbb due to the craniofacial defects we saw at E10.5. cbb mutants die shortly after birth. We show cbb embryos display defects that affect cells requiring the highest level of Shh activity. Furthermore, we find that the Smo protein in cbb mutants does not enrich properly in cilia.
Taken together, our data argue that proper ciliary Smo enrichment is necessary for full Smo activation.
Materials and methods

Mice
All mice were cared for in accordance with NIH guidelines and Emory's Institutional Animal Care and Use Committee (IACUC as previously published or as indicated below [35, 48] . Timed matings of heterozygous intercrosses were performed to generate embryos of the indicated stage, with somitematched pairs examined at each stage (E9.5, E10.5, E11.5). We saw no differences between wild-type or heterozygous Smo cbb embryos and show the heterozygous phenotype as backcrossed onto FVB/NJ, cbb was mapped to chromosome 6 using a low-density Illumina chip. The cbb mutation was refined to a 5-MB interval (D6Mit159 to D6Mit268) using SSLP marker-based PCR. Through whole-exome sequencing (Mouse Mutant Resequencing Project, Broad Institute) and subsequent analysis using SeqAnt, a cytosine-to-adenine SNP in exon 3 of the Smoothened (Smo) gene was identified [49] . Genotyping was performed by PCR using D6MIT159 primers (Fwd: 5′-CATATTCAAGACGGAGACTAGTTCC-3′, Rev: 5′-CACATGAAACACATGCACACA-3′) to amplify a strain-specific variation 3 kb upstream of the cbb point mutation. We confirmed the linkage of this marker via analysis of 225 E10.5 embryos from our breeding pedigree: 175/176 embryos phenotypically classified as normal genotyped as "control" (homozygous or heterozygous FVB at D6MIT159), and 49/49 embryos phenotypically classified as cbb genotyped as "mutant" (homozygous C57BL/6 at D6MIT159).
Phenotypic analysis of embryos and newborn pups
Embryos were dissected in cold phosphate-buffered saline and processed for β-galactosidase activity or immunofluorescence as previously described [50] . Antibodies used were: Shh, Nkx2.2 (Developmental Studies Hybridoma Bank; 1:5); FoxA2 (Cell Signaling; 1:500); Olig2 (Millipore; 1:300); Arl13b (NeuroMab 455-8JD-29; 1:500); Smo (kindly provided by K Anderson; 1:500); Alexa Fluor 488 and Alexa Fluor 568 (1:300, ThermoFisher); and Hoechst nuclear stain (1:3000). Alizarin red and alcian blue staining were performed as previously described [51, 52] .
Mouse embryonic fibroblasts
Mouse embryonic fibroblasts (MEFs) were isolated and immortalized as previously described [53] . Control and Smo cbb MEFs were grown on coverslips at a density of 0.5 × 10 6 cells/mL and treated for 24 h with 0.5% fetal bovine serum (FBS) Shh-conditioned medium [54] , 0.5% FBS medium containing 100 or 400 nM SAG (Millipore), 0.5% FBS medium containing 5 uM cyclopamine (Toronto Research Chemicals), or 0.5% FBS DMEM. Ten images were taken of each coverslip and scored by two independent reviewers blinded to genotype. Smo localization in cilia was categorized as full, partial, or negative ( Figure 6A ).
RT-qPCR analysis
Control and Smo cbb MEFs were treated with Shh-conditioned or 0.5% FBS media every 24 h and harvested after 24, 48, or 72 h. RNA was isolated by QIAshredder homogenizer columns and RNeasy kit (Qiagen) following the manufacturer's instructions. cDNA was synthesized with iScript Reverse Transcription Supermix (Bio-Rad) using 200 ng of RNA per reaction following the manufacturer's instructions. Primers used were: Ptch1 5′-TGCTGTGCCTGTGGTCATCCTGATT-3′, and 5′-CAGAGCGAGCATAGCCCTGTGGTTC-3′; Gli1 5′-CTTCACCCTGCCATGAAACT-3′, and 5′-TCCAGCTGAGTGTTGTCCAG-3′; Pold3 5′-ACGCTTGACAGGAGGGGGCT-3′, and 5′-AGGAGAAAAGCAGGGGCAAGCG-3′ [53] . RT-qPCR reactions were performed in technical triplicate on three biological replicates as previously described. Gli1 and Ptch1 expression levels were normalized to the corresponding Pold3 levels for each replicate.
Normalized RT-qPCR data were analyzed by ANOVA with Bonferroni correction for multiple comparisons.
Structural prediction
The Smo protein structure was modeled using PyMol (Version 2.0; Python) and UCSF Chimera resource (version 1.12) [55] . The mutation model was formed by 500 sequential iterations of energy minimization and geometry optimization on crystallized human Smo receptor bound to SAG ligand (PDB: 4QIN) [56] .
Results
cabbie is a novel Smoothened allele
We identified the cbb mutation in a recessive ENU screen for embryos with abnormal morphology at E10.5. cbb embryos displayed a reduced frontonasal prominence (FNP), and the nasal pits collapsed towards the midline ( Figure 1A ,B and Figure 2A ,B). We induced the cbb mutation on a C57BL/6 background and backcrossed to FVB so that we could use polymorphic markers and linkage analysis to map the cbb mutation. We found that cbb was located on chromosome 6. Through whole-exome sequencing, we identified a cytosine-toadenine transversion in exon 3 of the Smo gene. The change is predicted to mutate a conserved asparagine (amino acid 223) to a lysine ( Figure 1C ) at a position between the Nterminal cysteine-rich domain (CRD) and transmembrane domain 1 ( Figure 1D ).
To determine whether the C→A mutation underlies the cbb phenotype, we performed a complementation test with a null allele of Smo: bent body (bnb) [35, 57] . Smo bnb single mutant embryos display a distinct head shape, small body size, failed embryonic turning, and lethality just before E9.5 ( Figure 1G 
Smo cbb causes craniofacial and skeletal defects
To determine the functional consequences of the Smo cbb allele, we examined craniofacial and skeletal development since both processes depend on Hh signaling. Smo null embryos display a single medially located nasal pit by E9.0, their point of lethality [6, 35, 57] . In contrast, Smo cbb mutants were commonly indistinguishable from controls at E9.5 ( Figure  1F ). By E10.5, Smo cbb embryos display abnormal outgrowth of the nasal processes and a rotation of the nasal pits (Figure 2A 
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We examined the skeletons of Smo cbb embryos, where Shh and Ihh each play critical roles.
Despite the craniofacial defect, we found many of the bones of the skull developed in the appropriate size and position ( Figure 2G ,H). We saw that the long bones of Smo cbb postnatal day 0 (P0) pups were shorter than those of littermate controls ( Figure 2I ,J). In the caudal vertebral column, the centers of each vertebra ossify in the control pups ( Figure 2K ,S); however, in the Smo cbb pups, the vertebral bodies were barely present ( Figure 2L ,T). In the limbs, we consistently saw digit defects across Smo cbb pups, but the number of digits and presence of ossification centers varied in front-and hindlimb paws ( Figure 2O -R). In addition, the mandibles in Smo cbb embryos were consistently smaller than littermate controls, but in some cases, we observed premature fusion at the symphysis ( Figure 2M,N) . Such subtle phenotypic variability among Smo cbb mutants is consistent with this being a hypomorphic allele affecting processes that require the highest levels of Hh signaling.
Smo cbb mutant embryos display abnormal neural tube patterning
Neural cell fates in the embryonic neural tube depend on Shh activity [38] . To monitor Shh activity in the neural tube, we used a Ptch1-lacZ allele since Ptch1 is a transcriptional target of Shh signaling [48] . In the control neural tube at E10.5, we saw a steep ventral-to-dorsal gradient of lacZ staining, whereas in the neural tube of Smo cbb , we saw a diminished lacZ gradient, indicating reduced Shh activity ( Figure 3A Figure 3D ). The floor plate is the secondary signaling center that produces Shh ligand [41] and expresses FoxA2 ( Figure 3E ). In E10.5 Smo cbb mutants, we observed fewer FoxA2-positive cells, some co-expressing Nkx2.2 ( Figure 3F ). The motor neuron precursors (Olig2-positive) are dorsally adjacent to the Nkx2.2 population ( Figure 3G ). In Smo cbb mutants, the Olig2 cells expanded ventrally, but not dorsally, compared to control neural tubes ( Figure 3H ). Taken together, these data suggest that less Shh production in the floor plate leads to lowered Shh response at the ventral midline and the appropriate Shh response at the dorsal Olig2 boundary.
Progenitors in the neural tube are sensitive to both concentration and duration of Shh exposure [45] [46] [47] . 
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In vitro analysis of Shh-dependent transcriptional targets in cultured mutant fibroblasts
To directly examine the level of Shh response, we derived and immortalized mouse embryonic fibroblasts (MEFs) from Smo cbb and control littermates. We measured transcription of the Shh target genes Ptch1 and Gli1 in the absence and presence of Shh. In control MEFs, we found increased Gli1 and Ptch1 expression 24 hours after treatment with Shh ( Figure 4A, black 
N223K disrupts the Smo ligand-binding pocket and SAG binding to Smo
The asparagine-to-lysine change at position 223 in the Smo cbb allele is located within the linker domain of the protein, downstream of the cysteine-rich domain (CRD) and immediately prior to the beginning of transmembrane domain 1 (Figure 5A,B) . The corresponding residue in the human SMO receptor contributes to a ligand-binding pocket, where SMO agonists and antagonists bind. In fact, one solved crystal structure shows Smo agonist (SAG) associates with the ligand-binding pocket, and hydrogen bonds with the asparagine corresponding to N223 in the mouse protein [56, 59] . Based on the solved structure, we modeled the N223K mutation (N219K in human) and found that a change from asparagine to lysine is predicted to occlude the Smo binding pocket and interfere with the binding of SAG, a potent agonist ( Figure 5C,D MEFs was statistically lower than in control MEFs ( Figure 5E, red comparisons ). Next, we tested whether the Smo cbb MEFs could respond to a higher dose of SAG (400 nM, four times higher than in the previous experiment). This dose was also ineffective at increasing Shh transcriptional response in mutant MEFs, suggesting the N223K mutation renders the Smo receptor refractory to SAG. ( Figure 5F ). We note that while neither Shh nor SAG statistically induced Gli1 or Ptch1 expression, the slight response we detected in Shh-treated Smo cbb MEFs may be biologically distinct from the lack of expression we saw in SAGtreated Smo cbb MEFs (Figures 4A,5E ). Together, these data are consistent with the Smo N223K mutation altering the ligand-binding pocket, such that SAG cannot effectively bind and activate the receptor.
Smoothened localization defect in Smo cbb in vivo and in vitro after Shh and SAG activation
In vertebrates, Smo is enriched in cilia upon pathway activation, a step that is necessary but not sufficient for Smo activation [23, 24] . 
Discussion
Here, we identified a mouse mutant displaying craniofacial, skeletal, and neural tube patterning defects and showed the defects are due to a N223K mutation in the [56, 59, 60] . One proposed mechanism for this is via a cysteine-cysteine disulfide bond between the N-terminus and extracellular loop 1 mediated by residue C217 in hSMO [59] . Residue N219 in hSMO forms a critical hydrogen bond with SAG as part of the ligand-binding pocket. Without SAG, N219 forms two hydrogen bonds with L221 and D384 on extracellular loop 2. When bound to SAG, N219 releases its D384 bond and instead binds the SAG molecule, forming a lid on the ligand-binding pocket [56] . In a simulation of human SMO N219K ( Figure 5 ), the L221 bond is lost, and only the D384 association remains, which may disrupt SAG binding. Alternatively, lysine is a larger residue than asparagine and is predicted to structurally interfere with the binding of SAG. One of the most striking results in our studies was the fact that Smo cbb embryos survived to birth, implying some Hh transduction; however, Smo cbb MEFs did not display a statistically significant transcriptional response upon Shh stimulation, even after 72 hours of treatment ( Figure 4 ). One interpretation of these data is that the induction we saw in Smo cbb MEFs, while not statistically significant, is biologically significant. Consistent with this interpretation is the fact that we saw no induction of Gli1 or Ptch1 transcription when we stimulated the Smo cbb MEFs with moderate or high doses of SAG ( Figure 5C,D) . If this interpretation is correct, then the time course in MEFs would mean that the N223K mutation disrupts the actual activation status of Smo, as opposed to the kinetics of its activation. Of course, the alternative explanation is that MEFs in vitro do not reflect what occurs in the living embryo in vivo.
Our work in vivo provided an unexpected finding about the level of Shh signaling in the notochord. The notochord is the source of the Shh morphogen, which is why this is where the highest concentration of ligand is seen [3, 5] . Previous work showed that the notochord degenerates in the absence of Smo, arguing that Shh signaling is required to maintain the notochord [35] . Our analysis of Smo cbb mutants showed that the notochord was intact, but the floor plate was not properly specified, along with a clear deficit in Smo-positive cilia in the ventral floor plate. These data suggest that the floor plate, but not the notochord, requires the highest level of Shh signaling.
The reduced floor plate in Smo cbb mutants appears to produce less Shh ligand than in controls. In the improperly specified Smo cbb floor plate, we observed some Nkx2.2 and FoxA2 co-expressing cells, suggesting that cell identity is poorly defined at this stage. However, at E11.5, we noted a lack of co-labeled cells, suggesting that cell fates resolve over time. This indicates that Shh signal integration is delayed, but it does occur. That said, the simple model of neural patterning would predict that fewer floor plate cells expressing less Shh would lead to patterning defects in all the ventral cell fates. In fact, we observed the ventral expansion of Nkx2.2 and Olig2 fates but the dorsal position of the Olig2 domain was the same as in controls. This is reminiscent of Gli2 mutants, which also do not specify a floor plate, but display a ventral expansion of intermediate cell fates and maintain the dorsal position of the Olig2 domain [62, 63] . Thus, the highest levels of Shh response appear necessary exclusively at the ventral midline of the neural tube.
In Smo cbb mutants, the reduced floor plate, the lack of vertebral bodies in the backbone, the shortening of the long bones of the limbs, and the rotated nasal pits, all reflect a loss of the highest levels of Shh activity. In fact, the skeletal phenotype closely resembles that of the Gli2 null embryo that shares late gestational lethality [64] , further supporting a loss of highlevel Shh. While recent evidence suggests that Smo activation can occur in a ciliaindependent manner, the highest levels of activation appear to depend upon ciliary enrichment [65] . Smo is trafficked to cilia after the initial activation event that likely causes a change in its conformation in order to expose the C-terminal tail that is required for its ciliary enrichment [23] . G proteincoupled receptor associated sorting protein 2 (Gprasp2) interacts with the Smo C-terminus in addition to a protein, Pitchfork, in a complex that contains the kinesin Kif3b motor subunit [66] . 
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